Ignite Creation Date:
2024-05-06 @ 1:33 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04055493
Status:
RECRUITING
Last Update Posted:
2023-05-15
First Post:
2019-07-22
Brief Title:
Adj Marker-adjusted Personalized Therapy Comparing ETRibociclib vs Chemotherapy in Intermediate Risk HRHER2- EBC
Sponsor:
West German Study Group
Organization:
West German Study Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2027-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-22
First Submit QC Date:
August 12 2019
Study First Post Date:
2019-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-12
Last Update Post Date:
2023-05-15
Last Update Post Date Type:
ACTUAL